Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Yes, with the Ion GeneStudio S5 Series flexible chip format, your research accelerates across both small and large projects without the need to change instruments. The fast, automated workflow achieves sample to answer results across a broad range of applications.
Get more
| From less
|
Figure 1. Five Ion 5 Series chips achieve 2–130M reads per run to enable a broad range of applications. Reads per run shown are maximum reads per chip
Highly-referenced, single-platform solutions enabling low- and ultra-low sample inputs to comprehensively profile even the most challenging FFPE, liquid biopsy and immuno-oncology research samples.
Fixed, Made-to-Order, and On-Demand Ion AmpliSeq panels help you discover causal variants easily with a simple and fast Ion GeneStudio S5 sequencing workflow with nucleic acid-to-answer automation.
A flexible chip format enables you to cost-effectively process samples without batching—explore species diversity and abundance with the higher dynamic range achieved by the Ion GeneStudio S5 Series.
The Ion GeneStudio S5 Series enables applications from mRNA gene expression profiling to whole transcriptome sequencing.
Achieve ultralow frequency variant detection from both liquid biopsy and FFPE research samples with a new innovation in library preparation, Ion AmpliSeq HD technology—available later this year.
“Exome trios are straightforward in a single Ion 550 chip run. We’ve also run mouse transcriptome, DNA and RNA panels. Data quality is excellent; comparable with our Ion 540 chip data.”
—Adam Ameur, Genome Center, University of Uppsaala, Sweden
“We have already adopted the new chip in our workflows so that we can gain significant time and cost advantages.”
—Inger Jonasson, Department of Immunology, Genetics and Pathology, University of Uppsala, Sweden
*Automated library prep enabled for Ion AmpliSeq panels.
For Research Use Only. Not for use in diagnostic procedures. The content provided herein may relate to products that have not been officially released and is subject to change without notice.